PEAK

PEAK

Congressional Activity (1)
Vol
Congressional4 trades

Recent Activity

Mar 23, 2026 Congress
Michael McCaul sell
$100,001 - $250,000 — House
Feb 10, 2026 Congress
Gilbert Cisneros sell
$1,001 - $15,000 — House

Analyst Ratings

Historical distribution67% buy · 27 analysts · no recent coverage
8Strong Buy
10Buy
9Hold
0Sell
0Strong Sell

Congressional Trades

2 members: 2 buys, 2 sells
MemberPartyTypeAmount
Michael McCaulRSELL$100,001 - $250,000
Gilbert CisnerosDSELL$1,001 - $15,000
Michael McCaulRBUY$100,001 - $250,000

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 67% buy across 27 analysts — 8 strong buy, 10 buy, 9 hold, 0 sell, 0 strong sell. No current recommendation available.

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Feb 1, 202381090067%
Jan 1, 202371090065%
Dec 1, 202271180069%
Nov 1, 202271090065%
Strong BuyBuyHoldSellStrong Sell
2 members of Congress traded this stock: 2 buys, 2 sells.

Congressional Trades

DateMemberPartyChamberTypeAmountAssetDisclosed
Mar 23, 2026Michael McCaulRHOUSESELL$100,001 - $250,000Healthpeak Properties IncApr 10, 2026 (19d)
Feb 10, 2026Gilbert CisnerosDHOUSESELL$1,001 - $15,000Healthpeak Properties IncMar 10, 2026 (29d)
Feb 6, 2026Michael McCaulRHOUSEBUY$100,001 - $250,000Healthpeak Properties IncMar 12, 2026 (35d)
Jan 9, 2026Gilbert CisnerosDHOUSEBUY$1,001 - $15,000Healthpeak Properties IncFeb 16, 2026 (39d)

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.